(MedPage Today) -- Last week's season finale of "The Pitt" generated significant discussion, particularly around one of its most emotionally charged scenes: Dr. Al-Hashimi's disclosure to Dr. Robby that she has a seizure disorder causing brief...
(MedPage Today) -- Note that some links may require registration or subscription. Rep. Sheila Cherfilus-McCormick (D-Fla.) resigned from Congress; she and her brother are alleged to have stolen $5 million from COVID disaster relief funding given...
(MedPage Today) -- The Trump administration's nomination of Erica Schwartz, MD, MPH, JD, a former deputy surgeon general, to lead the CDC follows a review of the agency launched in January. HHS chief counselor Chris Klomp led the effort to identify...
(MedPage Today) -- The FDA approved islatravir-doravirine (Idvynso) as a standalone, single-tablet regimen for treating HIV in virologically suppressed adults, Merck announced on Tuesday. Approval stipulates use of the oral combination in patients...
(MedPage Today) -- As medical organizations, lawmakers, advocates -- and even the lead actor from "The Pitt" -- laud the reauthorization of the Lorna Breen Act through fiscal year 2030, they're also urging millions of dollars to boost funding...
(MedPage Today) -- Rep. Lori Trahan (D-Mass.) during a House hearing on Tuesday expressed her frustration with HHS Secretary Robert F. Kennedy Jr., noting that he "managed to give a 'Go Gators' from the witness table, but not a 'Go [vitamin] K...
(MedPage Today) -- At least some patients with inflammatory bowel disease (IBD) can safely use common drugs for musculoskeletal aches and pains, a large study of insurance claims data suggested, contradicting a widespread concern that these products...
(MedPage Today) -- SAN DIEGO -- Treatment with investigational elisrasib, a next-generation KRAS G12C inhibitor, showed efficacy in patients with advanced non-small cell lung cancer (NSCLC) with and without previous exposure to other KRAS G12C...
(MedPage Today) -- The Trump administration will require all 50 states to explain their plans to revalidate some of their Medicaid providers in a national escalation of anti-fraud efforts that have so far largely focused on specific states, Mehmet...
(MedPage Today) -- Real-world data suggested the dual GLP-1/GIP receptor agonist tirzepatide (Mounjaro, Zepbound) was associated with greater weight loss, but also muscle loss, compared with semaglutide (Ozempic, Wegovy), according to a medical...
(MedPage Today) -- Additional antihypertensive treatment with a three-drug polypill benefitted patients after intracerebral hemorrhage (ICH), the placebo-controlled TRIDENT trial found. Among ICH survivors already on good background therapy randomized...
(MedPage Today) -- The investigational benzamide antipsychotic N-methyl amisulpride (LB-102) led to significant symptom improvement among hospitalized adults with acute schizophrenia, a randomized trial showed. In this phase II study, the mean...